drugset / Trial / NCT01592227

A Study to Compare Two Paracetamol Formulations.

NCT01592227

Phase 1 Completed 30 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-label

Summary

A pharmacokinetic study investigating the rate and extent of absorption of paracetamol and an adjuvant from two different paracetamol formulations.

Timeline

Start
2009-12
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule

Indications

No indication recorded.